SlideShare uma empresa Scribd logo
1 de 31
CHRONIC TOXICITY
STUDIES-A BRIEF OUTLOOK
INTRODUCTION:
• TOXICITY: “Degree ,to which a substance (toxin/poison) can harm humans/animals”
• Toxicity can refer to the effects on:
1.Cell (CYTOTOXICITY)
2.Organ (Eg: RENAL/LIVER toxicity)
3.Whole organism
• This explains why scientists use different procedures to assess toxicity and to
provide an estimate of how much of a substance causes a kind of harm
• All substances are potentially toxic, depending on the QUANTITY
• Many therapeutic substances can be acutely toxic,but are beneficial,when used at
the appropriate level . Example : Vitamin D , Oxygen,Water (simplest examples)
CONTINUED……………
• A larger quantity of a substance does not automatically imply harm
• This is why toxicity determination is primarily focused on DETERMINING the TYPE
and DEGREE of HARM, caused by different amounts of a substance/drug
• Many serious toxic reactions caused by new chemical entities may be detected by
ROUTINE TOXICOLOGICAL TESTING
• Experience has shown that predictable “DOSE TIME DEPENDANT” reactions are
likely to be revealed in animal experiments
• These tests form the basis of EXPERIMENTAL TOXICOLOGY ,that is applied to every
new drug development / unknown substance
• There is NO MEASURE of toxicity, and its effects may occur in short term (acute
effects) , / after repeated exposure over a long period (sub-acute,sub-
chronic/chronic effects)
CONTINUED…………………….
 The following tests are conducted, using rodent models, for toxicity detection:
1. ACUTE TOXICITY TESTS (Single dose)
2. SUB-ACUTE TOXICITY TESTS (Daily dose : 14-28 days)
3. SUB-CHRONIC TOXICITY TESTS (Daily dose: up to 90 days)
4. CHRONIC TOXICITY TESTS (Daily dose: up to 12 months)
CHRONIC TOXICITY TESTING:
 Here we cover the following aspects:
1.INTRODUCTION
2.OECD GUIDELINES FOR TOXICITY
3.AIMS OF EXPERIMENT
4.BASIC REQUIREMENTS /INITIAL CONSIDERATIONS
5.PRINCIPLES OF TEST
6.METHOD DESCRIPTIONS
7.PROCEDURE
8.OBSERVATIONS
9.DATA AND REPORTING
10.CONCLUSION.
1. INTRODUCTION:
 Chronic toxicity test determines toxicity for a substantial portion of a subject’s life
 According to GHS (GLOBALLY HARMONIZED SYSTEM), it is defined as “ Specific TARGET
ORGAN / SYSTEMIC TOXICITY, arising from a REPEATED EXPOSURE up to 12 MONTHS”
 Consists of repeated doses(RDs) ,in ORAL, INHALATION AND DERMAL
ADMINISTRATION
 End points for RD testing consists of:
1.CLINICAL OBSERVATIONS
2.BLOOD ANALYSIS
3.WHOLE BODY GROSS NECROPSY
4.MICROSCOPIC EXAMINATION OF ALL ORGANS AND TISSUES (HISTOPATHOLOGY)
CONTINUED…………….
 Data from the aforesaid studies provide information on:
1.Cumulative exposure of target organs
2.General health hazards, which are likely to occur as a result of repeted low dose
exposure to a chemical
2. OECD GUIDELINES FOR TOXICITY:
 There are 6 OECD (ORGANIZATION FOR ECONOMIC CO-OPERATION AND
DEVELOPMENT) TEST GUIDELINES (TG),that describe short-term repeated dose
toxicity testing:
1. RD 28 day OT study in Rodents (OECD TG 407)
2. RD 90 day OT study in Rodents (OECD TG 408)
3. RD Dermal toxicity :21/28 day study (OECD TG 410)
4. Sub-chronic Dermal toxicity : 90 day study (OECD TG 411)
5. RD inhalation toxicity : 14/28 day study (OECD TG 412)
6. Sub-chronic inhalation toxicity : 90 day study (OECD TG 413)
3. AIMS OF THE EXPERIMENT:
 Repeat dosing toxicity studies are conducted to:
1.Determine side effects ,that may arise from repeated administration of a drug at
lower dosages than those used in acute toxicity studies
2.Determine safe dosages to be used in initial human clinical trials
3.Provide info on major toxic effects, indicate target organs and possibility of
accumulation……………….
4. BASIC REQUIREMENTS/INITIAL
CONSIDERATIONS:
 Info, that assists in selection of the appropriate test concentrations, include:
1.IDENTITY, CHEMICAL STRUCTURE and PHYSICOCHEMICAL FEATURES OF TEST
ARTICLE
2.RESULTS of any IN-VITRO / IN-VIVO TOXICITY TESTS
3.AVAILABLE QSAR data and TOXICOLOGICAL data on structurally related substances
4.Data, derived from ACUTE INHALATION TOXICITY TESTING
• Dilutions of corrosive / irritating test articles may be tested at concentrations that
will yield desired degree of toxicity
• While exposing animals to these materials, the targeted concentrations should be
low enough, so that it does not cause marked pain and distress, yet it is sufficient
to extend the CRC to levels that reach regulatory and scientific objectives of the
test………….
5.PRINCIPLES OF TEST:
 For oral/dermal testing:
Take test substance
Give dermally/orally in graduated doses, (as per need), to several groups of
experimental animals for a period of 12 months
During period of administration/application, animals are observed daily for
signs of toxicity
Animals that die during test are NECROPSIED, and the remaining survivors are
SACRIFICED and NECROPSIED.
6. METHOD DESCRIPTION:
 Includes:
A. Selection of animal species and sex
B. Housing and feeding conditions
C. Preparation of animals
D. Preparation of doses
A. Selection of animal species and sex:
 Mammals are selected to be the test animals
 Animals , with a clearly known ORIGIN, SPECIES and BREED should be used
 Preferred rodent is rat
 If other rodents are used, justification should be given for the same
 Smaller species should be avoided
 Smaller species can lead to problems, due to increased technical challenges of
dissecting smaller organs
 Young, healthy adult animals (not exceeding 9 months old) should be used
 Females should be non-pregnant
 Weight variation of animals should be minimal (not greater than 20% of mean weight of
each sex)
B. Housing and Feeding conditions:
 Animals should be individually identified ,using SUBCUTANEOUS TRANSPONDERS ,to facilitate
observations and AVOID CONFUSIONS
 All procedures should conform to the local standards of the LABORATORY ANIMAL CARE
 Temp. in experimental animal room should be in the range of (22-25) degrees
 Lighting should be artificial,(PHOTOPERIOD of 12 hour darkness and 12 hour light)
 For feeding, use conventional lab diets, along with an unlimited supply of water
 Choice of diet depends on the NEED to CO-ADMINISTER a test substance along with it
 Animals should be group housed in small groups of same sex (individually, if justified)
 For group caging, use not more than 5 animals per cage.
 Terminology: TRANSPONDER : Radio/radar transceiver ,that transmits signals in response to a
predetermined signal
C. Preparation of animals:
 Healthy animals, who have ACCLIMATIZED to lab conditions for ATLEAST 5 DAYS ,
and have not been subjected to PREVIOUS EXPERIMENTAL PROCEDURES should
be used
 Test animals should be characterized as to species, strain, source, sex, weight and /
age
 Cages should be arranged in such a way that possible effects due to cage
placement are decreased ……………
D. Preparation of doses:
 Test compound is administered varyingly, depending on the aims of study
 Method of oral administration depends on study purpose and physical/ chemical
properties of the test material
 If necessary, dissolve the test substance in a suitable vehicle
 Order of choice for test vehicle is: AQUEOUS SOLUTION> EMULSION IN OIL (Corn
oil) > Solution in other vehicles
 For solution in other vehicles , analyze the toxicity level of the vehicle
 Determine stability of the test substance ,under conditions of administrating the
same
7. PROCEDURE:
A. FOR ORAL TOXICITY STUDIES:
Take test animal
administer with test substance daily
- Route of administration can also be via stomach tube /intubation cannula(other than
normal routes of administration like intraperitoneal ,etc.),in special conditions like
“GAVAGE”
- Dose can be adjusted as per animal body weight
- Volume of liquid that is used to administer should not exceed 1 ml/100 g of body
weight (except for aq. Soln. : 2 ml/ 100 g allowed)
- While administering test substance with food,monitor:
i. Homogeneity
ii. Additive concentration
iii. Safety of test substance after it has been added
Continued…………………….
B. For dermal toxicity studies:
- Animals are treated with the test substance for at least 6 hrs./ day
- Test substance should be applied uniformly over an area approx. 10% of body
weight
- For highly toxic substances , surface area may be less
- Area should be covered with a thin and uniform film
- Between applications , the test substance is held in contact with skin using a gauze
dressing/ non-irritating tape
- Cover test site in order to retain gauze dressing
- Ensure that the animal cannot ingest the test substance…………..
8. OBSERVATION:
 Observation period should be about 90 days (in sub-chronic test) and about a year
(in chronic testing)
 Observations can be classified as :
A. GENERAL CONDITION AND DEATH RATE:
-Made once a day ,at the same time each day
-Consider peak levels of anticipated effects after dosing
-Record health condition of animals
-Observe all animals for MORBIDITY and MORTALITY at least TWICE DAILY
Continued………………
B. WEIGHT,FOOD AND WATER INTAKE ,FOOD INTAKE EFFICIENCY:
-Weigh all animals once a week
-Measure rate of food concentrations once a week
-If test substance is given via water, measure water consumption weekly
C. HAEMATOLOGICAL TESTS:
-Collect blood samples(at the end of test period,/ prior to killing animals, or as a part
of it),under appropriate conditions
-Observe for the following values:
Continued………………
i. Hematocrit
ii. Hb conc.
iii. Erythrocyte count
iv. TLC
v. DLC
vi. Platelet count
vii. Measure of blood clotting time/potential
Continued……………
D. BLOOD BIOCHEMISTRY TEST:
Used to investigate:
a. Toxic effects in tissues
b. Toxic effects in organs
-Test is performed on basis of blood samples obtained from each animal prior to /as part of
procedure
-Observe for the following serum values:
i. Sodium
ii. Potassium
iii. Glucose
iv. TC
v. Urea
vi. BUN
vii. Creatinine
viii. Total protein and albumin
Continued…………………
ix. More than 2 enzymes that indicate hepatocellular effects (AST, ALT,ALP,Sorbitol
dehydrogenase)
E. URINE TEST:
-Timely urine vol. collection
-Check for urine:
i. Appearance
ii. Vol.
iii. Specific gravity
iv. Ph.
v. Protein
vi. Glucose and blood cells
Continued……………………….
F. PATHOLOGY TESTS:
-Involves :
i. G/E
ii. M/E
- Subject all animals in study to a full, detailed, gross necropsy, that includes careful
examination of:
a. Ext. surface of body
b. All orifices
c. Cranial, thoracic and abd. Cavities, and their contents
Continued………………..
-Remove adherent tissue from liver, heart, kidney, uterus, testis, epididymis, ovaries,
adrenals etc.
- Determine wet weight after dissection to avoid drying
- Conduct full histopathology on preserved organs and tissues of all
animals………………
9. DATA AND REPORTING:
A. DATA:
-Provide individual statistical data in tabular form, that shows:
i. No. of test animals used
ii. No. of test animals found dead during test/euthanized for ethical reasons
iii. No. showing signs of toxicity
iv. Signs of toxicity
v. Time of onset, duration and severity of toxicity
vi. No. of animals showing lesions, their types and severity
Continued…………
B. TEST REPORT:
-Test report must include the following info:
i. Test substance
ii. Vehicle (if appropriate)
iii. Test animals
iv. Test conditions :
* Rationale for dose level selection
*Details of test substance formulation / diet preparation ,achieved conc. , stability and
preparation homogeneity
*Details of administration of test substance
*Actual doses (mg/kg body weight /day ) and conversion factor from diet/ drinking water
*Details of food and water quality
Continued…………………
v. Results:
*Body wt.
*Body wt. changes
*Food consumption and water concentration
*Toxic response data by sex and dose levels , including toxicity signs
*Nature, severity and duration of clinical observations (reversible / not)
*Ophthalmic exam. Results
*Sensory and motor activities
*Terminal body wt. ,organ wt. and organ body weight ratios
*Necropsy findings
*Detailed description of all pathologic findings
*Absorption data, if available
*Statistical results presentation
vi. Result discussion
vii. Conclusion
10. CONCLUSION:
 Chemical substance-given to subject-series of interactions and dose related
responses-most cases are desired and useful, and in some cases not useful and
harmful
 There are 4 types of toxicity in general
 Acute toxicity is involved in LD50 estimation, causing death to 50% of tested
groups of animals
 Sub-acute, sub-chronic and chronic toxicity studies are used to evaluate:
A. Characteristic toxic effects of drugs upon administration (RD) ,for periods of time,
ranging from 2 weeks- 1 year
B. No toxic effect dosage levels for short to long term repeat dosing………………….
11. REFERENCE/SUBSTANTIAL
BIBLIOGRAPHY:
DETERMINATION OF DRUG TOXICITY (EXPERIMENTAL MODELS IN RODENTS) , BY:
BOGDAN TAMBA
GEORGE FOLTEA
MAGDA LEON
RADU ILIESCU
THANK YOU!!!!   

Mais conteúdo relacionado

Mais procurados

Importance and application of toxicokinetics
Importance and application of toxicokineticsImportance and application of toxicokinetics
Importance and application of toxicokineticsPrajjwal Rajput
 
Safety pharmacology studies
Safety pharmacology studies Safety pharmacology studies
Safety pharmacology studies Santosh Sai
 
Toxicokinetic evaluation in preclinical studies by Shivam Diwaker
Toxicokinetic evaluation in preclinical studies by Shivam Diwaker Toxicokinetic evaluation in preclinical studies by Shivam Diwaker
Toxicokinetic evaluation in preclinical studies by Shivam Diwaker Shivam Diwaker
 
Male and female reproductive toxicology
Male and female reproductive toxicologyMale and female reproductive toxicology
Male and female reproductive toxicologyKhadga Raj
 
Acute oral toxicity-UDP : oecd-425
Acute oral toxicity-UDP : oecd-425Acute oral toxicity-UDP : oecd-425
Acute oral toxicity-UDP : oecd-425Dr Ajay Mandal
 
Toxicology & Regulatory Guidelines for Conducting Toxicity Study
Toxicology & Regulatory Guidelines for Conducting Toxicity StudyToxicology & Regulatory Guidelines for Conducting Toxicity Study
Toxicology & Regulatory Guidelines for Conducting Toxicity StudyJanhaviBurade
 
Reproductive toxicology studies ACCORDING TO OECD guidlines 422
Reproductive toxicology  studies ACCORDING TO OECD guidlines 422 Reproductive toxicology  studies ACCORDING TO OECD guidlines 422
Reproductive toxicology studies ACCORDING TO OECD guidlines 422 SONALPANDE5
 
Acute dermal toxicity-402
Acute dermal toxicity-402Acute dermal toxicity-402
Acute dermal toxicity-402Dr Ajay Mandal
 
SCREENING OF ANTI CANCER DRUGS
SCREENING OF ANTI CANCER DRUGSSCREENING OF ANTI CANCER DRUGS
SCREENING OF ANTI CANCER DRUGSRafa Zubair
 
Alternative methods to animal toxicity testing
Alternative methods to animal toxicity testingAlternative methods to animal toxicity testing
Alternative methods to animal toxicity testingSanchit Dhankhar
 
OECD Guidline on acute and chronic toxicity
OECD Guidline on acute and chronic toxicityOECD Guidline on acute and chronic toxicity
OECD Guidline on acute and chronic toxicityShital Magar
 
Toxicology | Definition | Types | Regulatory Guidelines | OECD Principles for...
Toxicology | Definition | Types | Regulatory Guidelines | OECD Principles for...Toxicology | Definition | Types | Regulatory Guidelines | OECD Principles for...
Toxicology | Definition | Types | Regulatory Guidelines | OECD Principles for...Chetan Prakash
 
Schedule y for toxicity studies
Schedule y  for toxicity studiesSchedule y  for toxicity studies
Schedule y for toxicity studiesKrushangiShah233
 
Regulatory guidelines for conducting toxicity studies
Regulatory guidelines for conducting toxicity studiesRegulatory guidelines for conducting toxicity studies
Regulatory guidelines for conducting toxicity studiesHimikaRathi
 
Acute oral toxicity –acute class method
Acute oral toxicity –acute class methodAcute oral toxicity –acute class method
Acute oral toxicity –acute class methodDr Ajay Mandal
 
Analgesic screening methods
Analgesic screening methodsAnalgesic screening methods
Analgesic screening methodsshubhaasharma
 

Mais procurados (20)

Importance and application of toxicokinetics
Importance and application of toxicokineticsImportance and application of toxicokinetics
Importance and application of toxicokinetics
 
Safety pharmacology studies
Safety pharmacology studies Safety pharmacology studies
Safety pharmacology studies
 
Toxicokinetic evaluation in preclinical studies by Shivam Diwaker
Toxicokinetic evaluation in preclinical studies by Shivam Diwaker Toxicokinetic evaluation in preclinical studies by Shivam Diwaker
Toxicokinetic evaluation in preclinical studies by Shivam Diwaker
 
Male and female reproductive toxicology
Male and female reproductive toxicologyMale and female reproductive toxicology
Male and female reproductive toxicology
 
Acute oral toxicity-UDP : oecd-425
Acute oral toxicity-UDP : oecd-425Acute oral toxicity-UDP : oecd-425
Acute oral toxicity-UDP : oecd-425
 
Toxicology & Regulatory Guidelines for Conducting Toxicity Study
Toxicology & Regulatory Guidelines for Conducting Toxicity StudyToxicology & Regulatory Guidelines for Conducting Toxicity Study
Toxicology & Regulatory Guidelines for Conducting Toxicity Study
 
OECD Guidelines
OECD GuidelinesOECD Guidelines
OECD Guidelines
 
Reproductive toxicology studies ACCORDING TO OECD guidlines 422
Reproductive toxicology  studies ACCORDING TO OECD guidlines 422 Reproductive toxicology  studies ACCORDING TO OECD guidlines 422
Reproductive toxicology studies ACCORDING TO OECD guidlines 422
 
Acute dermal toxicity-402
Acute dermal toxicity-402Acute dermal toxicity-402
Acute dermal toxicity-402
 
ACUTE, SUB ACUTE & CHRONIC TOXICOLOGICAL STUDIES
ACUTE, SUB ACUTE & CHRONIC TOXICOLOGICAL STUDIESACUTE, SUB ACUTE & CHRONIC TOXICOLOGICAL STUDIES
ACUTE, SUB ACUTE & CHRONIC TOXICOLOGICAL STUDIES
 
SCREENING OF ANTI CANCER DRUGS
SCREENING OF ANTI CANCER DRUGSSCREENING OF ANTI CANCER DRUGS
SCREENING OF ANTI CANCER DRUGS
 
Schedule y
Schedule ySchedule y
Schedule y
 
Alternative methods to animal toxicity testing
Alternative methods to animal toxicity testingAlternative methods to animal toxicity testing
Alternative methods to animal toxicity testing
 
Genotoxicity studies
Genotoxicity studiesGenotoxicity studies
Genotoxicity studies
 
OECD Guidline on acute and chronic toxicity
OECD Guidline on acute and chronic toxicityOECD Guidline on acute and chronic toxicity
OECD Guidline on acute and chronic toxicity
 
Toxicology | Definition | Types | Regulatory Guidelines | OECD Principles for...
Toxicology | Definition | Types | Regulatory Guidelines | OECD Principles for...Toxicology | Definition | Types | Regulatory Guidelines | OECD Principles for...
Toxicology | Definition | Types | Regulatory Guidelines | OECD Principles for...
 
Schedule y for toxicity studies
Schedule y  for toxicity studiesSchedule y  for toxicity studies
Schedule y for toxicity studies
 
Regulatory guidelines for conducting toxicity studies
Regulatory guidelines for conducting toxicity studiesRegulatory guidelines for conducting toxicity studies
Regulatory guidelines for conducting toxicity studies
 
Acute oral toxicity –acute class method
Acute oral toxicity –acute class methodAcute oral toxicity –acute class method
Acute oral toxicity –acute class method
 
Analgesic screening methods
Analgesic screening methodsAnalgesic screening methods
Analgesic screening methods
 

Destaque

Subacute toxicity
Subacute toxicitySubacute toxicity
Subacute toxicityvaniarlekar
 
Animal toxicology studies
Animal toxicology studiesAnimal toxicology studies
Animal toxicology studiesswati2084
 
animal toxicity studies
animal toxicity studiesanimal toxicity studies
animal toxicity studiesVishnu Vardhan
 
Introduction to General toxicology
Introduction to General toxicologyIntroduction to General toxicology
Introduction to General toxicologyBADAR UDDIN UMAR
 
Palmoplantar pustolar psoriasis induced with infliximab in treating crohn di...
Palmoplantar pustolar psoriasis induced  with infliximab in treating crohn di...Palmoplantar pustolar psoriasis induced  with infliximab in treating crohn di...
Palmoplantar pustolar psoriasis induced with infliximab in treating crohn di...Dr. Faramarz Didar
 
International Guidelines and Regulatory Agencies for Toxicity Studies
International Guidelines and Regulatory Agencies for Toxicity StudiesInternational Guidelines and Regulatory Agencies for Toxicity Studies
International Guidelines and Regulatory Agencies for Toxicity StudiesSuneal Saini
 
INNOVATIONS AND REGULATIONS OF AYURVEDIC SYSTEMS
INNOVATIONS AND REGULATIONS OF AYURVEDIC SYSTEMSINNOVATIONS AND REGULATIONS OF AYURVEDIC SYSTEMS
INNOVATIONS AND REGULATIONS OF AYURVEDIC SYSTEMSMushtaq Ahmad Wani
 
GENERAL GUIDELINES FOR TOXICOPATHOLOGY STUDY
GENERAL GUIDELINES FOR TOXICOPATHOLOGY STUDYGENERAL GUIDELINES FOR TOXICOPATHOLOGY STUDY
GENERAL GUIDELINES FOR TOXICOPATHOLOGY STUDYRahul Kadam
 
Hans Steinkellner - Metabolites for dietary risk assessment
Hans Steinkellner - Metabolites for dietary risk assessmentHans Steinkellner - Metabolites for dietary risk assessment
Hans Steinkellner - Metabolites for dietary risk assessmentcropprotection
 
Current Pharmacology & Toxicology Guidlines For Pharmaceutical Industry
Current Pharmacology & Toxicology Guidlines For Pharmaceutical IndustryCurrent Pharmacology & Toxicology Guidlines For Pharmaceutical Industry
Current Pharmacology & Toxicology Guidlines For Pharmaceutical IndustryProf. Dr. Basavaraj Nanjwade
 
Psoriasi dalla diagnosi agli approcci clinici
Psoriasi dalla diagnosi agli  approcci cliniciPsoriasi dalla diagnosi agli  approcci clinici
Psoriasi dalla diagnosi agli approcci cliniciMaria De Chiaro
 
Perfect sample preparation. Is complete and holistic extraction of odourants ...
Perfect sample preparation. Is complete and holistic extraction of odourants ...Perfect sample preparation. Is complete and holistic extraction of odourants ...
Perfect sample preparation. Is complete and holistic extraction of odourants ...Waltham Centre for Pet Nutrition
 
OECG Dermatotoxicity testing
OECG Dermatotoxicity testingOECG Dermatotoxicity testing
OECG Dermatotoxicity testingSandip Chaudhari
 
Toxicology part 2
Toxicology part 2Toxicology part 2
Toxicology part 2akifab93
 

Destaque (20)

Subacute toxicity
Subacute toxicitySubacute toxicity
Subacute toxicity
 
Animal toxicology studies
Animal toxicology studiesAnimal toxicology studies
Animal toxicology studies
 
animal toxicity studies
animal toxicity studiesanimal toxicity studies
animal toxicity studies
 
INTRODUCTION TO TOXICOLOGY
INTRODUCTION TO TOXICOLOGYINTRODUCTION TO TOXICOLOGY
INTRODUCTION TO TOXICOLOGY
 
Toxic studies
Toxic studiesToxic studies
Toxic studies
 
Pravin fianl
Pravin fianlPravin fianl
Pravin fianl
 
Toxicological screening
Toxicological screeningToxicological screening
Toxicological screening
 
Introduction to General toxicology
Introduction to General toxicologyIntroduction to General toxicology
Introduction to General toxicology
 
Pre Clinical Studies
Pre Clinical StudiesPre Clinical Studies
Pre Clinical Studies
 
Palmoplantar pustolar psoriasis induced with infliximab in treating crohn di...
Palmoplantar pustolar psoriasis induced  with infliximab in treating crohn di...Palmoplantar pustolar psoriasis induced  with infliximab in treating crohn di...
Palmoplantar pustolar psoriasis induced with infliximab in treating crohn di...
 
International Guidelines and Regulatory Agencies for Toxicity Studies
International Guidelines and Regulatory Agencies for Toxicity StudiesInternational Guidelines and Regulatory Agencies for Toxicity Studies
International Guidelines and Regulatory Agencies for Toxicity Studies
 
INNOVATIONS AND REGULATIONS OF AYURVEDIC SYSTEMS
INNOVATIONS AND REGULATIONS OF AYURVEDIC SYSTEMSINNOVATIONS AND REGULATIONS OF AYURVEDIC SYSTEMS
INNOVATIONS AND REGULATIONS OF AYURVEDIC SYSTEMS
 
GENERAL GUIDELINES FOR TOXICOPATHOLOGY STUDY
GENERAL GUIDELINES FOR TOXICOPATHOLOGY STUDYGENERAL GUIDELINES FOR TOXICOPATHOLOGY STUDY
GENERAL GUIDELINES FOR TOXICOPATHOLOGY STUDY
 
Hans Steinkellner - Metabolites for dietary risk assessment
Hans Steinkellner - Metabolites for dietary risk assessmentHans Steinkellner - Metabolites for dietary risk assessment
Hans Steinkellner - Metabolites for dietary risk assessment
 
Api & afi
Api & afiApi & afi
Api & afi
 
Current Pharmacology & Toxicology Guidlines For Pharmaceutical Industry
Current Pharmacology & Toxicology Guidlines For Pharmaceutical IndustryCurrent Pharmacology & Toxicology Guidlines For Pharmaceutical Industry
Current Pharmacology & Toxicology Guidlines For Pharmaceutical Industry
 
Psoriasi dalla diagnosi agli approcci clinici
Psoriasi dalla diagnosi agli  approcci cliniciPsoriasi dalla diagnosi agli  approcci clinici
Psoriasi dalla diagnosi agli approcci clinici
 
Perfect sample preparation. Is complete and holistic extraction of odourants ...
Perfect sample preparation. Is complete and holistic extraction of odourants ...Perfect sample preparation. Is complete and holistic extraction of odourants ...
Perfect sample preparation. Is complete and holistic extraction of odourants ...
 
OECG Dermatotoxicity testing
OECG Dermatotoxicity testingOECG Dermatotoxicity testing
OECG Dermatotoxicity testing
 
Toxicology part 2
Toxicology part 2Toxicology part 2
Toxicology part 2
 

Semelhante a Chronic toxicity studies a brief outlook

chronic dermal and inhalational studies as per OECD
chronic dermal and inhalational studies as per OECDchronic dermal and inhalational studies as per OECD
chronic dermal and inhalational studies as per OECDSohil Shah
 
OECD Dermal testing By Priya.pptx
OECD Dermal testing By Priya.pptxOECD Dermal testing By Priya.pptx
OECD Dermal testing By Priya.pptxPriya818982
 
Chronic Toxicity Study (OECD TG-452).pptx
Chronic Toxicity Study (OECD TG-452).pptxChronic Toxicity Study (OECD TG-452).pptx
Chronic Toxicity Study (OECD TG-452).pptxSIRAJUDDIN MOLLA
 
Oecd for chronic toxicity
Oecd for chronic toxicityOecd for chronic toxicity
Oecd for chronic toxicitypavanreddy292
 
ptsm2 , unit 2 ( acute dermal toxicity) By; priyashree.pptx
ptsm2 , unit 2 ( acute dermal toxicity) By; priyashree.pptxptsm2 , unit 2 ( acute dermal toxicity) By; priyashree.pptx
ptsm2 , unit 2 ( acute dermal toxicity) By; priyashree.pptxPriyashreeK1
 
OECD Guideline 420: Acute oral Toxicity - Fixed Dose Procedure
OECD Guideline 420: Acute oral Toxicity - Fixed Dose ProcedureOECD Guideline 420: Acute oral Toxicity - Fixed Dose Procedure
OECD Guideline 420: Acute oral Toxicity - Fixed Dose ProcedureKhushbooThakur15
 
OECD Test Guideline 420: Acute Oral Toxicity - Fixed Dose
OECD Test Guideline 420: Acute Oral Toxicity - Fixed DoseOECD Test Guideline 420: Acute Oral Toxicity - Fixed Dose
OECD Test Guideline 420: Acute Oral Toxicity - Fixed Dosepp_shivgunde
 
Oecd 541 guidelines
Oecd 541 guidelinesOecd 541 guidelines
Oecd 541 guidelinesGOPAL KHODVE
 
General toxicology
General toxicologyGeneral toxicology
General toxicologyAsif Yahya
 
Acute dermal toxicity studies
Acute dermal toxicity studies Acute dermal toxicity studies
Acute dermal toxicity studies jeshicabulsara
 
INHALATIONAL TOXICITY STUDIES.M pharmacy
INHALATIONAL TOXICITY STUDIES.M pharmacyINHALATIONAL TOXICITY STUDIES.M pharmacy
INHALATIONAL TOXICITY STUDIES.M pharmacyAartiPal23
 
Pre clinical studies
Pre clinical studiesPre clinical studies
Pre clinical studiesKirsha K S
 
In vivo Carcinogenesity study PHARMACY.pptx
In vivo Carcinogenesity study PHARMACY.pptxIn vivo Carcinogenesity study PHARMACY.pptx
In vivo Carcinogenesity study PHARMACY.pptxsubhamsourajit1
 
OECD guidelines-Organisation for Economic Co-operation and Development guidel...
OECD guidelines-Organisation for Economic Co-operation and Development guidel...OECD guidelines-Organisation for Economic Co-operation and Development guidel...
OECD guidelines-Organisation for Economic Co-operation and Development guidel...Hemadharshini Senthill
 
toxicitytesting-200920120607.pdf
toxicitytesting-200920120607.pdftoxicitytesting-200920120607.pdf
toxicitytesting-200920120607.pdfChijiokeNsofor
 

Semelhante a Chronic toxicity studies a brief outlook (20)

chronic dermal and inhalational studies as per OECD
chronic dermal and inhalational studies as per OECDchronic dermal and inhalational studies as per OECD
chronic dermal and inhalational studies as per OECD
 
OECD Dermal testing By Priya.pptx
OECD Dermal testing By Priya.pptxOECD Dermal testing By Priya.pptx
OECD Dermal testing By Priya.pptx
 
Oecd guidelines
Oecd guidelinesOecd guidelines
Oecd guidelines
 
Chronic Toxicity Study (OECD TG-452).pptx
Chronic Toxicity Study (OECD TG-452).pptxChronic Toxicity Study (OECD TG-452).pptx
Chronic Toxicity Study (OECD TG-452).pptx
 
Oecd for chronic toxicity
Oecd for chronic toxicityOecd for chronic toxicity
Oecd for chronic toxicity
 
ptsm2 , unit 2 ( acute dermal toxicity) By; priyashree.pptx
ptsm2 , unit 2 ( acute dermal toxicity) By; priyashree.pptxptsm2 , unit 2 ( acute dermal toxicity) By; priyashree.pptx
ptsm2 , unit 2 ( acute dermal toxicity) By; priyashree.pptx
 
Oecd guide line2
Oecd guide line2Oecd guide line2
Oecd guide line2
 
Oecd guide line2
Oecd guide line2Oecd guide line2
Oecd guide line2
 
OECD Guideline 420: Acute oral Toxicity - Fixed Dose Procedure
OECD Guideline 420: Acute oral Toxicity - Fixed Dose ProcedureOECD Guideline 420: Acute oral Toxicity - Fixed Dose Procedure
OECD Guideline 420: Acute oral Toxicity - Fixed Dose Procedure
 
OECD Test Guideline 420: Acute Oral Toxicity - Fixed Dose
OECD Test Guideline 420: Acute Oral Toxicity - Fixed DoseOECD Test Guideline 420: Acute Oral Toxicity - Fixed Dose
OECD Test Guideline 420: Acute Oral Toxicity - Fixed Dose
 
Difference between toxicity studies
Difference between toxicity studiesDifference between toxicity studies
Difference between toxicity studies
 
Oecd 541 guidelines
Oecd 541 guidelinesOecd 541 guidelines
Oecd 541 guidelines
 
General toxicology
General toxicologyGeneral toxicology
General toxicology
 
Acute dermal toxicity studies
Acute dermal toxicity studies Acute dermal toxicity studies
Acute dermal toxicity studies
 
INHALATIONAL TOXICITY STUDIES.M pharmacy
INHALATIONAL TOXICITY STUDIES.M pharmacyINHALATIONAL TOXICITY STUDIES.M pharmacy
INHALATIONAL TOXICITY STUDIES.M pharmacy
 
Pre clinical studies
Pre clinical studiesPre clinical studies
Pre clinical studies
 
Tocixity studies
Tocixity studiesTocixity studies
Tocixity studies
 
In vivo Carcinogenesity study PHARMACY.pptx
In vivo Carcinogenesity study PHARMACY.pptxIn vivo Carcinogenesity study PHARMACY.pptx
In vivo Carcinogenesity study PHARMACY.pptx
 
OECD guidelines-Organisation for Economic Co-operation and Development guidel...
OECD guidelines-Organisation for Economic Co-operation and Development guidel...OECD guidelines-Organisation for Economic Co-operation and Development guidel...
OECD guidelines-Organisation for Economic Co-operation and Development guidel...
 
toxicitytesting-200920120607.pdf
toxicitytesting-200920120607.pdftoxicitytesting-200920120607.pdf
toxicitytesting-200920120607.pdf
 

Mais de RxVichuZ

Parkinson Disease Pathophysiology #Dr. Vishnu!
Parkinson Disease Pathophysiology #Dr. Vishnu!Parkinson Disease Pathophysiology #Dr. Vishnu!
Parkinson Disease Pathophysiology #Dr. Vishnu!RxVichuZ
 
HIV Pathophysiology, by Dr. Vishnu
HIV Pathophysiology, by Dr. VishnuHIV Pathophysiology, by Dr. Vishnu
HIV Pathophysiology, by Dr. VishnuRxVichuZ
 
General principles involved in management of poisoning (Part 1)
General principles involved in management of poisoning (Part 1)General principles involved in management of poisoning (Part 1)
General principles involved in management of poisoning (Part 1)RxVichuZ
 
Buprenorphine drug profile by Dr. Vishnu!
Buprenorphine drug profile by Dr. Vishnu!Buprenorphine drug profile by Dr. Vishnu!
Buprenorphine drug profile by Dr. Vishnu!RxVichuZ
 
5-Alpha reductase inhibitors drug profile
5-Alpha reductase inhibitors drug profile5-Alpha reductase inhibitors drug profile
5-Alpha reductase inhibitors drug profileRxVichuZ
 
Rational use of antibiotics by RxVichuZ!
Rational use of antibiotics by RxVichuZ!Rational use of antibiotics by RxVichuZ!
Rational use of antibiotics by RxVichuZ!RxVichuZ
 
Co-trimoxazole drug profile by RxVichuZ!
Co-trimoxazole drug profile by RxVichuZ!Co-trimoxazole drug profile by RxVichuZ!
Co-trimoxazole drug profile by RxVichuZ!RxVichuZ
 
Amoxicillin drug profile: By RxVichuZ! :)
Amoxicillin drug profile: By RxVichuZ! :)Amoxicillin drug profile: By RxVichuZ! :)
Amoxicillin drug profile: By RxVichuZ! :)RxVichuZ
 
Food drug interactions with penicillins: by RxVichuZ!
Food drug interactions with penicillins: by RxVichuZ!Food drug interactions with penicillins: by RxVichuZ!
Food drug interactions with penicillins: by RxVichuZ!RxVichuZ
 
Snake bite poisoning and its treatment by RxVichuZ!
Snake bite poisoning and its treatment by RxVichuZ!Snake bite poisoning and its treatment by RxVichuZ!
Snake bite poisoning and its treatment by RxVichuZ!RxVichuZ
 
Case study on Heart Failure by RxVichuZ!
Case study on Heart Failure by RxVichuZ!Case study on Heart Failure by RxVichuZ!
Case study on Heart Failure by RxVichuZ!RxVichuZ
 
Directly acting antivirals and Visceral Leishmaniasis: A case report
Directly acting antivirals and Visceral Leishmaniasis: A case reportDirectly acting antivirals and Visceral Leishmaniasis: A case report
Directly acting antivirals and Visceral Leishmaniasis: A case reportRxVichuZ
 
Drug mnemonics; by RxVichuZ! ;)
Drug mnemonics; by RxVichuZ! ;)Drug mnemonics; by RxVichuZ! ;)
Drug mnemonics; by RxVichuZ! ;)RxVichuZ
 
Acute coronary syndrome management by RxVichuZ! ;)
Acute coronary syndrome management by RxVichuZ! ;)Acute coronary syndrome management by RxVichuZ! ;)
Acute coronary syndrome management by RxVichuZ! ;)RxVichuZ
 
RNTCP guidelines for tuberculosis management: Extended version
RNTCP guidelines for tuberculosis management: Extended versionRNTCP guidelines for tuberculosis management: Extended version
RNTCP guidelines for tuberculosis management: Extended versionRxVichuZ
 
Journal club presentation: by RxVichuZ!! ;)
Journal club presentation: by RxVichuZ!! ;)Journal club presentation: by RxVichuZ!! ;)
Journal club presentation: by RxVichuZ!! ;)RxVichuZ
 
PPI-INDUCED BICYTOPENIA: MATTER OF CONCERN by RxVichuZ! ;)
PPI-INDUCED BICYTOPENIA: MATTER OF CONCERN by RxVichuZ! ;)PPI-INDUCED BICYTOPENIA: MATTER OF CONCERN by RxVichuZ! ;)
PPI-INDUCED BICYTOPENIA: MATTER OF CONCERN by RxVichuZ! ;)RxVichuZ
 
Dipeptidyl peptidase inhibitors(DPP-IV): A deep insight
Dipeptidyl peptidase inhibitors(DPP-IV): A deep insightDipeptidyl peptidase inhibitors(DPP-IV): A deep insight
Dipeptidyl peptidase inhibitors(DPP-IV): A deep insightRxVichuZ
 
Principles of cancer chemotherapy: a deep insight by RxVichuZ!
Principles of cancer chemotherapy: a deep insight by RxVichuZ!Principles of cancer chemotherapy: a deep insight by RxVichuZ!
Principles of cancer chemotherapy: a deep insight by RxVichuZ!RxVichuZ
 
Sulfonylureas for Diabetes: A deep insight
Sulfonylureas for Diabetes: A deep insightSulfonylureas for Diabetes: A deep insight
Sulfonylureas for Diabetes: A deep insightRxVichuZ
 

Mais de RxVichuZ (20)

Parkinson Disease Pathophysiology #Dr. Vishnu!
Parkinson Disease Pathophysiology #Dr. Vishnu!Parkinson Disease Pathophysiology #Dr. Vishnu!
Parkinson Disease Pathophysiology #Dr. Vishnu!
 
HIV Pathophysiology, by Dr. Vishnu
HIV Pathophysiology, by Dr. VishnuHIV Pathophysiology, by Dr. Vishnu
HIV Pathophysiology, by Dr. Vishnu
 
General principles involved in management of poisoning (Part 1)
General principles involved in management of poisoning (Part 1)General principles involved in management of poisoning (Part 1)
General principles involved in management of poisoning (Part 1)
 
Buprenorphine drug profile by Dr. Vishnu!
Buprenorphine drug profile by Dr. Vishnu!Buprenorphine drug profile by Dr. Vishnu!
Buprenorphine drug profile by Dr. Vishnu!
 
5-Alpha reductase inhibitors drug profile
5-Alpha reductase inhibitors drug profile5-Alpha reductase inhibitors drug profile
5-Alpha reductase inhibitors drug profile
 
Rational use of antibiotics by RxVichuZ!
Rational use of antibiotics by RxVichuZ!Rational use of antibiotics by RxVichuZ!
Rational use of antibiotics by RxVichuZ!
 
Co-trimoxazole drug profile by RxVichuZ!
Co-trimoxazole drug profile by RxVichuZ!Co-trimoxazole drug profile by RxVichuZ!
Co-trimoxazole drug profile by RxVichuZ!
 
Amoxicillin drug profile: By RxVichuZ! :)
Amoxicillin drug profile: By RxVichuZ! :)Amoxicillin drug profile: By RxVichuZ! :)
Amoxicillin drug profile: By RxVichuZ! :)
 
Food drug interactions with penicillins: by RxVichuZ!
Food drug interactions with penicillins: by RxVichuZ!Food drug interactions with penicillins: by RxVichuZ!
Food drug interactions with penicillins: by RxVichuZ!
 
Snake bite poisoning and its treatment by RxVichuZ!
Snake bite poisoning and its treatment by RxVichuZ!Snake bite poisoning and its treatment by RxVichuZ!
Snake bite poisoning and its treatment by RxVichuZ!
 
Case study on Heart Failure by RxVichuZ!
Case study on Heart Failure by RxVichuZ!Case study on Heart Failure by RxVichuZ!
Case study on Heart Failure by RxVichuZ!
 
Directly acting antivirals and Visceral Leishmaniasis: A case report
Directly acting antivirals and Visceral Leishmaniasis: A case reportDirectly acting antivirals and Visceral Leishmaniasis: A case report
Directly acting antivirals and Visceral Leishmaniasis: A case report
 
Drug mnemonics; by RxVichuZ! ;)
Drug mnemonics; by RxVichuZ! ;)Drug mnemonics; by RxVichuZ! ;)
Drug mnemonics; by RxVichuZ! ;)
 
Acute coronary syndrome management by RxVichuZ! ;)
Acute coronary syndrome management by RxVichuZ! ;)Acute coronary syndrome management by RxVichuZ! ;)
Acute coronary syndrome management by RxVichuZ! ;)
 
RNTCP guidelines for tuberculosis management: Extended version
RNTCP guidelines for tuberculosis management: Extended versionRNTCP guidelines for tuberculosis management: Extended version
RNTCP guidelines for tuberculosis management: Extended version
 
Journal club presentation: by RxVichuZ!! ;)
Journal club presentation: by RxVichuZ!! ;)Journal club presentation: by RxVichuZ!! ;)
Journal club presentation: by RxVichuZ!! ;)
 
PPI-INDUCED BICYTOPENIA: MATTER OF CONCERN by RxVichuZ! ;)
PPI-INDUCED BICYTOPENIA: MATTER OF CONCERN by RxVichuZ! ;)PPI-INDUCED BICYTOPENIA: MATTER OF CONCERN by RxVichuZ! ;)
PPI-INDUCED BICYTOPENIA: MATTER OF CONCERN by RxVichuZ! ;)
 
Dipeptidyl peptidase inhibitors(DPP-IV): A deep insight
Dipeptidyl peptidase inhibitors(DPP-IV): A deep insightDipeptidyl peptidase inhibitors(DPP-IV): A deep insight
Dipeptidyl peptidase inhibitors(DPP-IV): A deep insight
 
Principles of cancer chemotherapy: a deep insight by RxVichuZ!
Principles of cancer chemotherapy: a deep insight by RxVichuZ!Principles of cancer chemotherapy: a deep insight by RxVichuZ!
Principles of cancer chemotherapy: a deep insight by RxVichuZ!
 
Sulfonylureas for Diabetes: A deep insight
Sulfonylureas for Diabetes: A deep insightSulfonylureas for Diabetes: A deep insight
Sulfonylureas for Diabetes: A deep insight
 

Último

Call Girl Bangalore Nandini 7001305949 Independent Escort Service Bangalore
Call Girl Bangalore Nandini 7001305949 Independent Escort Service BangaloreCall Girl Bangalore Nandini 7001305949 Independent Escort Service Bangalore
Call Girl Bangalore Nandini 7001305949 Independent Escort Service Bangalorenarwatsonia7
 
Call Girls Electronic City Just Call 7001305949 Top Class Call Girl Service A...
Call Girls Electronic City Just Call 7001305949 Top Class Call Girl Service A...Call Girls Electronic City Just Call 7001305949 Top Class Call Girl Service A...
Call Girls Electronic City Just Call 7001305949 Top Class Call Girl Service A...narwatsonia7
 
VIP Call Girls Mumbai Arpita 9910780858 Independent Escort Service Mumbai
VIP Call Girls Mumbai Arpita 9910780858 Independent Escort Service MumbaiVIP Call Girls Mumbai Arpita 9910780858 Independent Escort Service Mumbai
VIP Call Girls Mumbai Arpita 9910780858 Independent Escort Service Mumbaisonalikaur4
 
Russian Call Girl Brookfield - 7001305949 Escorts Service 50% Off with Cash O...
Russian Call Girl Brookfield - 7001305949 Escorts Service 50% Off with Cash O...Russian Call Girl Brookfield - 7001305949 Escorts Service 50% Off with Cash O...
Russian Call Girl Brookfield - 7001305949 Escorts Service 50% Off with Cash O...narwatsonia7
 
Low Rate Call Girls Mumbai Suman 9910780858 Independent Escort Service Mumbai
Low Rate Call Girls Mumbai Suman 9910780858 Independent Escort Service MumbaiLow Rate Call Girls Mumbai Suman 9910780858 Independent Escort Service Mumbai
Low Rate Call Girls Mumbai Suman 9910780858 Independent Escort Service Mumbaisonalikaur4
 
Call Girls Jp Nagar Just Call 7001305949 Top Class Call Girl Service Available
Call Girls Jp Nagar Just Call 7001305949 Top Class Call Girl Service AvailableCall Girls Jp Nagar Just Call 7001305949 Top Class Call Girl Service Available
Call Girls Jp Nagar Just Call 7001305949 Top Class Call Girl Service Availablenarwatsonia7
 
Glomerular Filtration rate and its determinants.pptx
Glomerular Filtration rate and its determinants.pptxGlomerular Filtration rate and its determinants.pptx
Glomerular Filtration rate and its determinants.pptxDr.Nusrat Tariq
 
High Profile Call Girls Jaipur Vani 8445551418 Independent Escort Service Jaipur
High Profile Call Girls Jaipur Vani 8445551418 Independent Escort Service JaipurHigh Profile Call Girls Jaipur Vani 8445551418 Independent Escort Service Jaipur
High Profile Call Girls Jaipur Vani 8445551418 Independent Escort Service Jaipurparulsinha
 
Asthma Review - GINA guidelines summary 2024
Asthma Review - GINA guidelines summary 2024Asthma Review - GINA guidelines summary 2024
Asthma Review - GINA guidelines summary 2024Gabriel Guevara MD
 
Call Girls Frazer Town Just Call 7001305949 Top Class Call Girl Service Avail...
Call Girls Frazer Town Just Call 7001305949 Top Class Call Girl Service Avail...Call Girls Frazer Town Just Call 7001305949 Top Class Call Girl Service Avail...
Call Girls Frazer Town Just Call 7001305949 Top Class Call Girl Service Avail...narwatsonia7
 
Call Girls Jayanagar Just Call 7001305949 Top Class Call Girl Service Available
Call Girls Jayanagar Just Call 7001305949 Top Class Call Girl Service AvailableCall Girls Jayanagar Just Call 7001305949 Top Class Call Girl Service Available
Call Girls Jayanagar Just Call 7001305949 Top Class Call Girl Service Availablenarwatsonia7
 
Call Girls Whitefield Just Call 7001305949 Top Class Call Girl Service Available
Call Girls Whitefield Just Call 7001305949 Top Class Call Girl Service AvailableCall Girls Whitefield Just Call 7001305949 Top Class Call Girl Service Available
Call Girls Whitefield Just Call 7001305949 Top Class Call Girl Service Availablenarwatsonia7
 
Call Girl Koramangala | 7001305949 At Low Cost Cash Payment Booking
Call Girl Koramangala | 7001305949 At Low Cost Cash Payment BookingCall Girl Koramangala | 7001305949 At Low Cost Cash Payment Booking
Call Girl Koramangala | 7001305949 At Low Cost Cash Payment Bookingnarwatsonia7
 
97111 47426 Call Girls In Delhi MUNIRKAA
97111 47426 Call Girls In Delhi MUNIRKAA97111 47426 Call Girls In Delhi MUNIRKAA
97111 47426 Call Girls In Delhi MUNIRKAAjennyeacort
 
Call Girls Service Noida Maya 9711199012 Independent Escort Service Noida
Call Girls Service Noida Maya 9711199012 Independent Escort Service NoidaCall Girls Service Noida Maya 9711199012 Independent Escort Service Noida
Call Girls Service Noida Maya 9711199012 Independent Escort Service NoidaPooja Gupta
 
Call Girls Hosur Just Call 7001305949 Top Class Call Girl Service Available
Call Girls Hosur Just Call 7001305949 Top Class Call Girl Service AvailableCall Girls Hosur Just Call 7001305949 Top Class Call Girl Service Available
Call Girls Hosur Just Call 7001305949 Top Class Call Girl Service Availablenarwatsonia7
 
Glomerular Filtration and determinants of glomerular filtration .pptx
Glomerular Filtration and  determinants of glomerular filtration .pptxGlomerular Filtration and  determinants of glomerular filtration .pptx
Glomerular Filtration and determinants of glomerular filtration .pptxDr.Nusrat Tariq
 
Mumbai Call Girls Service 9910780858 Real Russian Girls Looking Models
Mumbai Call Girls Service 9910780858 Real Russian Girls Looking ModelsMumbai Call Girls Service 9910780858 Real Russian Girls Looking Models
Mumbai Call Girls Service 9910780858 Real Russian Girls Looking Modelssonalikaur4
 
call girls in green park DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in green park  DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️call girls in green park  DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in green park DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️saminamagar
 
call girls in munirka DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in munirka  DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️call girls in munirka  DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in munirka DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️saminamagar
 

Último (20)

Call Girl Bangalore Nandini 7001305949 Independent Escort Service Bangalore
Call Girl Bangalore Nandini 7001305949 Independent Escort Service BangaloreCall Girl Bangalore Nandini 7001305949 Independent Escort Service Bangalore
Call Girl Bangalore Nandini 7001305949 Independent Escort Service Bangalore
 
Call Girls Electronic City Just Call 7001305949 Top Class Call Girl Service A...
Call Girls Electronic City Just Call 7001305949 Top Class Call Girl Service A...Call Girls Electronic City Just Call 7001305949 Top Class Call Girl Service A...
Call Girls Electronic City Just Call 7001305949 Top Class Call Girl Service A...
 
VIP Call Girls Mumbai Arpita 9910780858 Independent Escort Service Mumbai
VIP Call Girls Mumbai Arpita 9910780858 Independent Escort Service MumbaiVIP Call Girls Mumbai Arpita 9910780858 Independent Escort Service Mumbai
VIP Call Girls Mumbai Arpita 9910780858 Independent Escort Service Mumbai
 
Russian Call Girl Brookfield - 7001305949 Escorts Service 50% Off with Cash O...
Russian Call Girl Brookfield - 7001305949 Escorts Service 50% Off with Cash O...Russian Call Girl Brookfield - 7001305949 Escorts Service 50% Off with Cash O...
Russian Call Girl Brookfield - 7001305949 Escorts Service 50% Off with Cash O...
 
Low Rate Call Girls Mumbai Suman 9910780858 Independent Escort Service Mumbai
Low Rate Call Girls Mumbai Suman 9910780858 Independent Escort Service MumbaiLow Rate Call Girls Mumbai Suman 9910780858 Independent Escort Service Mumbai
Low Rate Call Girls Mumbai Suman 9910780858 Independent Escort Service Mumbai
 
Call Girls Jp Nagar Just Call 7001305949 Top Class Call Girl Service Available
Call Girls Jp Nagar Just Call 7001305949 Top Class Call Girl Service AvailableCall Girls Jp Nagar Just Call 7001305949 Top Class Call Girl Service Available
Call Girls Jp Nagar Just Call 7001305949 Top Class Call Girl Service Available
 
Glomerular Filtration rate and its determinants.pptx
Glomerular Filtration rate and its determinants.pptxGlomerular Filtration rate and its determinants.pptx
Glomerular Filtration rate and its determinants.pptx
 
High Profile Call Girls Jaipur Vani 8445551418 Independent Escort Service Jaipur
High Profile Call Girls Jaipur Vani 8445551418 Independent Escort Service JaipurHigh Profile Call Girls Jaipur Vani 8445551418 Independent Escort Service Jaipur
High Profile Call Girls Jaipur Vani 8445551418 Independent Escort Service Jaipur
 
Asthma Review - GINA guidelines summary 2024
Asthma Review - GINA guidelines summary 2024Asthma Review - GINA guidelines summary 2024
Asthma Review - GINA guidelines summary 2024
 
Call Girls Frazer Town Just Call 7001305949 Top Class Call Girl Service Avail...
Call Girls Frazer Town Just Call 7001305949 Top Class Call Girl Service Avail...Call Girls Frazer Town Just Call 7001305949 Top Class Call Girl Service Avail...
Call Girls Frazer Town Just Call 7001305949 Top Class Call Girl Service Avail...
 
Call Girls Jayanagar Just Call 7001305949 Top Class Call Girl Service Available
Call Girls Jayanagar Just Call 7001305949 Top Class Call Girl Service AvailableCall Girls Jayanagar Just Call 7001305949 Top Class Call Girl Service Available
Call Girls Jayanagar Just Call 7001305949 Top Class Call Girl Service Available
 
Call Girls Whitefield Just Call 7001305949 Top Class Call Girl Service Available
Call Girls Whitefield Just Call 7001305949 Top Class Call Girl Service AvailableCall Girls Whitefield Just Call 7001305949 Top Class Call Girl Service Available
Call Girls Whitefield Just Call 7001305949 Top Class Call Girl Service Available
 
Call Girl Koramangala | 7001305949 At Low Cost Cash Payment Booking
Call Girl Koramangala | 7001305949 At Low Cost Cash Payment BookingCall Girl Koramangala | 7001305949 At Low Cost Cash Payment Booking
Call Girl Koramangala | 7001305949 At Low Cost Cash Payment Booking
 
97111 47426 Call Girls In Delhi MUNIRKAA
97111 47426 Call Girls In Delhi MUNIRKAA97111 47426 Call Girls In Delhi MUNIRKAA
97111 47426 Call Girls In Delhi MUNIRKAA
 
Call Girls Service Noida Maya 9711199012 Independent Escort Service Noida
Call Girls Service Noida Maya 9711199012 Independent Escort Service NoidaCall Girls Service Noida Maya 9711199012 Independent Escort Service Noida
Call Girls Service Noida Maya 9711199012 Independent Escort Service Noida
 
Call Girls Hosur Just Call 7001305949 Top Class Call Girl Service Available
Call Girls Hosur Just Call 7001305949 Top Class Call Girl Service AvailableCall Girls Hosur Just Call 7001305949 Top Class Call Girl Service Available
Call Girls Hosur Just Call 7001305949 Top Class Call Girl Service Available
 
Glomerular Filtration and determinants of glomerular filtration .pptx
Glomerular Filtration and  determinants of glomerular filtration .pptxGlomerular Filtration and  determinants of glomerular filtration .pptx
Glomerular Filtration and determinants of glomerular filtration .pptx
 
Mumbai Call Girls Service 9910780858 Real Russian Girls Looking Models
Mumbai Call Girls Service 9910780858 Real Russian Girls Looking ModelsMumbai Call Girls Service 9910780858 Real Russian Girls Looking Models
Mumbai Call Girls Service 9910780858 Real Russian Girls Looking Models
 
call girls in green park DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in green park  DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️call girls in green park  DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in green park DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
 
call girls in munirka DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in munirka  DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️call girls in munirka  DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in munirka DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
 

Chronic toxicity studies a brief outlook

  • 2. INTRODUCTION: • TOXICITY: “Degree ,to which a substance (toxin/poison) can harm humans/animals” • Toxicity can refer to the effects on: 1.Cell (CYTOTOXICITY) 2.Organ (Eg: RENAL/LIVER toxicity) 3.Whole organism • This explains why scientists use different procedures to assess toxicity and to provide an estimate of how much of a substance causes a kind of harm • All substances are potentially toxic, depending on the QUANTITY • Many therapeutic substances can be acutely toxic,but are beneficial,when used at the appropriate level . Example : Vitamin D , Oxygen,Water (simplest examples)
  • 3. CONTINUED…………… • A larger quantity of a substance does not automatically imply harm • This is why toxicity determination is primarily focused on DETERMINING the TYPE and DEGREE of HARM, caused by different amounts of a substance/drug • Many serious toxic reactions caused by new chemical entities may be detected by ROUTINE TOXICOLOGICAL TESTING • Experience has shown that predictable “DOSE TIME DEPENDANT” reactions are likely to be revealed in animal experiments • These tests form the basis of EXPERIMENTAL TOXICOLOGY ,that is applied to every new drug development / unknown substance • There is NO MEASURE of toxicity, and its effects may occur in short term (acute effects) , / after repeated exposure over a long period (sub-acute,sub- chronic/chronic effects)
  • 4. CONTINUED…………………….  The following tests are conducted, using rodent models, for toxicity detection: 1. ACUTE TOXICITY TESTS (Single dose) 2. SUB-ACUTE TOXICITY TESTS (Daily dose : 14-28 days) 3. SUB-CHRONIC TOXICITY TESTS (Daily dose: up to 90 days) 4. CHRONIC TOXICITY TESTS (Daily dose: up to 12 months)
  • 5. CHRONIC TOXICITY TESTING:  Here we cover the following aspects: 1.INTRODUCTION 2.OECD GUIDELINES FOR TOXICITY 3.AIMS OF EXPERIMENT 4.BASIC REQUIREMENTS /INITIAL CONSIDERATIONS 5.PRINCIPLES OF TEST 6.METHOD DESCRIPTIONS 7.PROCEDURE 8.OBSERVATIONS 9.DATA AND REPORTING 10.CONCLUSION.
  • 6. 1. INTRODUCTION:  Chronic toxicity test determines toxicity for a substantial portion of a subject’s life  According to GHS (GLOBALLY HARMONIZED SYSTEM), it is defined as “ Specific TARGET ORGAN / SYSTEMIC TOXICITY, arising from a REPEATED EXPOSURE up to 12 MONTHS”  Consists of repeated doses(RDs) ,in ORAL, INHALATION AND DERMAL ADMINISTRATION  End points for RD testing consists of: 1.CLINICAL OBSERVATIONS 2.BLOOD ANALYSIS 3.WHOLE BODY GROSS NECROPSY 4.MICROSCOPIC EXAMINATION OF ALL ORGANS AND TISSUES (HISTOPATHOLOGY)
  • 7. CONTINUED…………….  Data from the aforesaid studies provide information on: 1.Cumulative exposure of target organs 2.General health hazards, which are likely to occur as a result of repeted low dose exposure to a chemical
  • 8. 2. OECD GUIDELINES FOR TOXICITY:  There are 6 OECD (ORGANIZATION FOR ECONOMIC CO-OPERATION AND DEVELOPMENT) TEST GUIDELINES (TG),that describe short-term repeated dose toxicity testing: 1. RD 28 day OT study in Rodents (OECD TG 407) 2. RD 90 day OT study in Rodents (OECD TG 408) 3. RD Dermal toxicity :21/28 day study (OECD TG 410) 4. Sub-chronic Dermal toxicity : 90 day study (OECD TG 411) 5. RD inhalation toxicity : 14/28 day study (OECD TG 412) 6. Sub-chronic inhalation toxicity : 90 day study (OECD TG 413)
  • 9. 3. AIMS OF THE EXPERIMENT:  Repeat dosing toxicity studies are conducted to: 1.Determine side effects ,that may arise from repeated administration of a drug at lower dosages than those used in acute toxicity studies 2.Determine safe dosages to be used in initial human clinical trials 3.Provide info on major toxic effects, indicate target organs and possibility of accumulation……………….
  • 10. 4. BASIC REQUIREMENTS/INITIAL CONSIDERATIONS:  Info, that assists in selection of the appropriate test concentrations, include: 1.IDENTITY, CHEMICAL STRUCTURE and PHYSICOCHEMICAL FEATURES OF TEST ARTICLE 2.RESULTS of any IN-VITRO / IN-VIVO TOXICITY TESTS 3.AVAILABLE QSAR data and TOXICOLOGICAL data on structurally related substances 4.Data, derived from ACUTE INHALATION TOXICITY TESTING • Dilutions of corrosive / irritating test articles may be tested at concentrations that will yield desired degree of toxicity • While exposing animals to these materials, the targeted concentrations should be low enough, so that it does not cause marked pain and distress, yet it is sufficient to extend the CRC to levels that reach regulatory and scientific objectives of the test………….
  • 11. 5.PRINCIPLES OF TEST:  For oral/dermal testing: Take test substance Give dermally/orally in graduated doses, (as per need), to several groups of experimental animals for a period of 12 months During period of administration/application, animals are observed daily for signs of toxicity Animals that die during test are NECROPSIED, and the remaining survivors are SACRIFICED and NECROPSIED.
  • 12. 6. METHOD DESCRIPTION:  Includes: A. Selection of animal species and sex B. Housing and feeding conditions C. Preparation of animals D. Preparation of doses
  • 13. A. Selection of animal species and sex:  Mammals are selected to be the test animals  Animals , with a clearly known ORIGIN, SPECIES and BREED should be used  Preferred rodent is rat  If other rodents are used, justification should be given for the same  Smaller species should be avoided  Smaller species can lead to problems, due to increased technical challenges of dissecting smaller organs  Young, healthy adult animals (not exceeding 9 months old) should be used  Females should be non-pregnant  Weight variation of animals should be minimal (not greater than 20% of mean weight of each sex)
  • 14. B. Housing and Feeding conditions:  Animals should be individually identified ,using SUBCUTANEOUS TRANSPONDERS ,to facilitate observations and AVOID CONFUSIONS  All procedures should conform to the local standards of the LABORATORY ANIMAL CARE  Temp. in experimental animal room should be in the range of (22-25) degrees  Lighting should be artificial,(PHOTOPERIOD of 12 hour darkness and 12 hour light)  For feeding, use conventional lab diets, along with an unlimited supply of water  Choice of diet depends on the NEED to CO-ADMINISTER a test substance along with it  Animals should be group housed in small groups of same sex (individually, if justified)  For group caging, use not more than 5 animals per cage.  Terminology: TRANSPONDER : Radio/radar transceiver ,that transmits signals in response to a predetermined signal
  • 15. C. Preparation of animals:  Healthy animals, who have ACCLIMATIZED to lab conditions for ATLEAST 5 DAYS , and have not been subjected to PREVIOUS EXPERIMENTAL PROCEDURES should be used  Test animals should be characterized as to species, strain, source, sex, weight and / age  Cages should be arranged in such a way that possible effects due to cage placement are decreased ……………
  • 16. D. Preparation of doses:  Test compound is administered varyingly, depending on the aims of study  Method of oral administration depends on study purpose and physical/ chemical properties of the test material  If necessary, dissolve the test substance in a suitable vehicle  Order of choice for test vehicle is: AQUEOUS SOLUTION> EMULSION IN OIL (Corn oil) > Solution in other vehicles  For solution in other vehicles , analyze the toxicity level of the vehicle  Determine stability of the test substance ,under conditions of administrating the same
  • 17. 7. PROCEDURE: A. FOR ORAL TOXICITY STUDIES: Take test animal administer with test substance daily - Route of administration can also be via stomach tube /intubation cannula(other than normal routes of administration like intraperitoneal ,etc.),in special conditions like “GAVAGE” - Dose can be adjusted as per animal body weight - Volume of liquid that is used to administer should not exceed 1 ml/100 g of body weight (except for aq. Soln. : 2 ml/ 100 g allowed) - While administering test substance with food,monitor: i. Homogeneity ii. Additive concentration iii. Safety of test substance after it has been added
  • 18. Continued……………………. B. For dermal toxicity studies: - Animals are treated with the test substance for at least 6 hrs./ day - Test substance should be applied uniformly over an area approx. 10% of body weight - For highly toxic substances , surface area may be less - Area should be covered with a thin and uniform film - Between applications , the test substance is held in contact with skin using a gauze dressing/ non-irritating tape - Cover test site in order to retain gauze dressing - Ensure that the animal cannot ingest the test substance…………..
  • 19. 8. OBSERVATION:  Observation period should be about 90 days (in sub-chronic test) and about a year (in chronic testing)  Observations can be classified as : A. GENERAL CONDITION AND DEATH RATE: -Made once a day ,at the same time each day -Consider peak levels of anticipated effects after dosing -Record health condition of animals -Observe all animals for MORBIDITY and MORTALITY at least TWICE DAILY
  • 20. Continued……………… B. WEIGHT,FOOD AND WATER INTAKE ,FOOD INTAKE EFFICIENCY: -Weigh all animals once a week -Measure rate of food concentrations once a week -If test substance is given via water, measure water consumption weekly C. HAEMATOLOGICAL TESTS: -Collect blood samples(at the end of test period,/ prior to killing animals, or as a part of it),under appropriate conditions -Observe for the following values:
  • 21. Continued……………… i. Hematocrit ii. Hb conc. iii. Erythrocyte count iv. TLC v. DLC vi. Platelet count vii. Measure of blood clotting time/potential
  • 22. Continued…………… D. BLOOD BIOCHEMISTRY TEST: Used to investigate: a. Toxic effects in tissues b. Toxic effects in organs -Test is performed on basis of blood samples obtained from each animal prior to /as part of procedure -Observe for the following serum values: i. Sodium ii. Potassium iii. Glucose iv. TC v. Urea vi. BUN vii. Creatinine viii. Total protein and albumin
  • 23. Continued………………… ix. More than 2 enzymes that indicate hepatocellular effects (AST, ALT,ALP,Sorbitol dehydrogenase) E. URINE TEST: -Timely urine vol. collection -Check for urine: i. Appearance ii. Vol. iii. Specific gravity iv. Ph. v. Protein vi. Glucose and blood cells
  • 24. Continued………………………. F. PATHOLOGY TESTS: -Involves : i. G/E ii. M/E - Subject all animals in study to a full, detailed, gross necropsy, that includes careful examination of: a. Ext. surface of body b. All orifices c. Cranial, thoracic and abd. Cavities, and their contents
  • 25. Continued……………….. -Remove adherent tissue from liver, heart, kidney, uterus, testis, epididymis, ovaries, adrenals etc. - Determine wet weight after dissection to avoid drying - Conduct full histopathology on preserved organs and tissues of all animals………………
  • 26. 9. DATA AND REPORTING: A. DATA: -Provide individual statistical data in tabular form, that shows: i. No. of test animals used ii. No. of test animals found dead during test/euthanized for ethical reasons iii. No. showing signs of toxicity iv. Signs of toxicity v. Time of onset, duration and severity of toxicity vi. No. of animals showing lesions, their types and severity
  • 27. Continued………… B. TEST REPORT: -Test report must include the following info: i. Test substance ii. Vehicle (if appropriate) iii. Test animals iv. Test conditions : * Rationale for dose level selection *Details of test substance formulation / diet preparation ,achieved conc. , stability and preparation homogeneity *Details of administration of test substance *Actual doses (mg/kg body weight /day ) and conversion factor from diet/ drinking water *Details of food and water quality
  • 28. Continued………………… v. Results: *Body wt. *Body wt. changes *Food consumption and water concentration *Toxic response data by sex and dose levels , including toxicity signs *Nature, severity and duration of clinical observations (reversible / not) *Ophthalmic exam. Results *Sensory and motor activities *Terminal body wt. ,organ wt. and organ body weight ratios *Necropsy findings *Detailed description of all pathologic findings *Absorption data, if available *Statistical results presentation vi. Result discussion vii. Conclusion
  • 29. 10. CONCLUSION:  Chemical substance-given to subject-series of interactions and dose related responses-most cases are desired and useful, and in some cases not useful and harmful  There are 4 types of toxicity in general  Acute toxicity is involved in LD50 estimation, causing death to 50% of tested groups of animals  Sub-acute, sub-chronic and chronic toxicity studies are used to evaluate: A. Characteristic toxic effects of drugs upon administration (RD) ,for periods of time, ranging from 2 weeks- 1 year B. No toxic effect dosage levels for short to long term repeat dosing………………….
  • 30. 11. REFERENCE/SUBSTANTIAL BIBLIOGRAPHY: DETERMINATION OF DRUG TOXICITY (EXPERIMENTAL MODELS IN RODENTS) , BY: BOGDAN TAMBA GEORGE FOLTEA MAGDA LEON RADU ILIESCU
  • 31. THANK YOU!!!!   